Cough and angioedema from angiotensin-converting enzyme inhibitors: New insights into mechanisms and management

Current Opinion in Allergy and Clinical Immunology

Volumn 4, Issue 4, 2004, Pages 267-270

  Dykewicz, Mark S ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioedema; Angiotensin receptor antagonists; Angiotensin converting enzyme inhibitors; Cough

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BACLOFEN; BRADYKININ; CROMOGLYCATE DISODIUM; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FRESH FROZEN PLASMA; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOCAL ANESTHETIC AGENT; LOSARTAN; NITRIC OXIDE; PICOTAMIDE; PLACEBO; PROSTACYCLIN; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; THROMBOXANE; VALSARTAN;

ANGIONEUROTIC EDEMA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; ESSENTIAL HYPERTENSION; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK BENEFIT ANALYSIS;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACLOFEN; COUGH; CROMOLYN SODIUM; HUMANS; HYPERTENSION; MUSCLE RELAXANTS, CENTRAL; RECEPTORS, ANGIOTENSIN; SULINDAC;

EID: 3442877524     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.all.0000136759.43571.7f     Document Type: Review

References (30)

1. Visser LE, Stricker BH, van der Velden J, et al. Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study. J Clin Epidemiol 1995; 48:851-857.
2. Elliott WJ, Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects. Clin Pharmacol Ther 1996; 60:582-588.
3. Trifilieff A, Da Silva A, Gies JP. Kinins and respiratory tract diseases. Eur Respir J 1993; 6:576-587.
4. Malini PL, Strocchi E, Zanardi M, et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997; 350:15-18.
5. Grossman E, Messer'l FH, Neutal JM. Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors? Arch Int Med 2000; 160:1905-1911.
6. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996; 38:281-306.
7. Liu YH, Yang XP, Sharov VG, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99:1926-1935.
8. Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31:349-355.
9. Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losarten Cough Study Group. J Hypertens 1994; 12:1387-1393.
10. Paster RZ, Snavely DB, Sweet AR, et al. Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin- converting enzyme inhibitors. Clin Ther 1998; 20:978-989.
11. Benz J, Oshrain C, Henry D, et al. Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. J Clin Pharmacol 1997; 37:101-107.
12. Allen TL, Gora-Harper ML. Cromolyn sodium for ACE inhibitor-induced cough. Ann Pharmacother 1997; 31:773-775.
13. Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration 1998; 65:86-88.
14. Luque CA, Vazquez Ortiz M. Treatment of ACE inhibitor-induced cough. Pharmacotherapy 1999; 19:804-810.
15. Meune C, Mahe I, Mourad JJ, et al. Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review. Eur J Clin Pharmacol 2000; 56:609-620.
16. Tenenbaum A, Grossman E, Shemesh J, et al. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens 2000; 13:776-782.
17. Fisman EZ, Grossman E, Motro M, et al. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors. J Hum Hypertens 2002; 16:379-383.
18. Lee SC, Park SW, Kim DK, et al. Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension 2001; 38:166-170.
19. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema: incidence, prevention and management. Drug Safety 1998; 18:171-188.
20. Kostis JB, Packer M, Black HR, et al. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004; 17:103-111. This large-scale study provides an estimate of the incidence of angioedema associated with the use of the ACE inhibitor enalapril.
21. Orfan N, Patterson R, Dykewicz MS. Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema. JAMA 1990; 264:1287-1289
22. Agostoni A, Cicardi M. Contraindications to the use of ace inhibitors in patients with C1 esterase inhibitor deficiency [Case report]. Am J Med 1991; 90:278.
23. Molinaro G, Cugno M, Perez M, et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. J Pharmacol Exp Ther 2002; 303:232-237.
24. Adam A, Cugno M, Molinaro G, et al. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 2002; 359:2088-2089.
25. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002; 347:621-622.
26. Abdi R, Dong VM, Lee CJ, Ntosso KA. Angiotensin II receptor blocker-asociated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy 2002; 22:1173-1175.
27. Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Safety 2002; 25:73-76.
28. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004; 164:910-913. An excellent retrospective study that provides perspective about the relatively low incidence of intolerance of angiotensin II receptor blockers in patients with a history of angioedema from ACE inhibitors.
29. Karim MY, Masood A. Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema. J Allergy Clin Immunol 2002; 109:370-371.
30. Warrer MR, Copilevitz, Dykewicz MD, Slavin RG, Fresh frozen plasma (FFP) in the treatment of resistant ACE inhibitor angioedema. Ann Allergy Asthma Immunol 2004; 92:573-575.